Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
NCT01571349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2013-12-25
Summary
The investigators are trying to investigate the coagulation status of idiopathic (immune) thrombocytopenic purpura patients by measuring the platelet count, coagulation battery, von Willebrand factor level, thromboelastography.
Conditions
- Idiopathic Thrombocytopenic Purpura
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Gaab Soo Kim, MD, PhD · Samsung Medical Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids
NCT06568913 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Observational Study on Immune Thrombocytopenia
NCT07068425 ·Status: NOT_YET_RECRUITING
-
H. Pylori Eradication for Moderate ITP
NCT03177629 ·Status: UNKNOWN ·Phase: PHASE3
-
The International ITP Registry
NCT01970189 ·Status: UNKNOWN
-
Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599 ·Status: COMPLETED ·Phase: PHASE3
-
Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
NCT01510873 ·Status: COMPLETED
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)
NCT02821572 ·Status: RECRUITING
-
Study of Immune Thrombocytopenia Pathogenesis:
NCT02042560 ·Status: COMPLETED
-
Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura
NCT07310342 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
"Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"
NCT07014904 ·Status: NOT_YET_RECRUITING
-
Helicobacter Pylori Immune Thrombocytopenic Purpura
NCT01255332 ·Status: UNKNOWN
-
Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment
NCT01864512 ·Status: WITHDRAWN
-
Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06107582 ·Status: RECRUITING
-
Bleeding Prediction in Thrombocytopenia
NCT02306044 ·Status: COMPLETED
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP
NCT05410249 ·Status: UNKNOWN
-
Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)
NCT04949009 ·Status: UNKNOWN
-
Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura
NCT06137105 ·Status: NOT_YET_RECRUITING
-
A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)
NCT03164915 ·Status: COMPLETED ·Phase: PHASE3
-
Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)
NCT05371743 ·Status: UNKNOWN
-
Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients
NCT02614846 ·Status: UNKNOWN ·Phase: PHASE1
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING